北京市东城区建国门内大街 26 号新闻大厦 7 层、8 层 电话：010-88004488/66090088 传真：010-66090016 邮编：100005 北京国枫律师事务所 关于雅本化学股份有限公司 国枫律股字[2025]A0619 号 致：雅本化学股份有限公司（"贵公司"或"雅本化学"） 北京国枫律师事务所（以下简称"本所"）接受贵公司的委托，指派律师出席并见 证贵公司 2025 年第四次临时股东会（以下简称"本次会议"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《律师事务所从事证券法律业务管理 办法》（以下简称"《证券法律业务管理办法》"）、《律师事务所证券法律业务执业规则（试 行）》（以下简称"《证券法律业务执业规则》"）等相关法律、行政法规、规章、规范性 文件及《雅本化学股份有限公司章程》（以下简称"《公司章程》"）的规定，就本次会 议的召集与召开程序、召集人资格、出席会议人员资格、会议表决程序及表决结果等事 宜，出具本法律意见书。 对本法律意见书的出具，本所律师特作如下声明： 1．本所律师仅就本次会议的召集与召开 ...

Group 1 - The core point of the article is that Yabao Chemical has reported a total of 53,905 shareholders as of December 10, 2025 [2]

Core Insights - The article highlights the journey and achievements of Cai Tong, the founder of Yabao Chemical, emphasizing his unique interdisciplinary background and strategic vision in the fine chemical industry [2][3]. Company Development - Yabao Chemical has focused on deepening its core business layout, particularly in the pharmaceutical sector, by signing a strategic cooperation agreement with leading domestic pharmaceutical company Heng Rui Medicine to enhance the quality and efficiency of its pharmaceutical business [3]. - The company has established its Malta base as a bridge for international business, equipped with EU GMP certification and formulation repackaging capabilities, facilitating domestic pharmaceutical companies' expansion into overseas markets [3]. - In the agrochemical intermediate sector, Yabao Chemical is concentrating on innovative, green, and efficient CDMO services, maintaining strategic partnerships with international agrochemical firms such as Corteva, Bayer, and FMC to solidify its leading position in niche markets [3]. Innovation and Investment - During the 14th Five-Year Plan period, Yabao Chemical has invested nearly 600 million yuan in research and development, prioritizing technological innovation as a core growth engine and establishing an AI research laboratory to build an intelligent R&D system [3]. - The company aims to create a diversified business structure encompassing pharmaceuticals, agrochemicals, and other sectors, referred to as "Pharmaceuticals + Agrochemicals + X" [3]. Recognition and Contributions - Cai Tong has received various accolades for his contributions to the industry and society, including the 2010 Taicang City First Lou Dong Talent Award and the 2013 Outstanding Person in China's Service Outsourcing Award [4]. - He holds multiple positions in educational and industry associations, contributing to talent cultivation and regional industrial collaboration [4].

Core Insights - The company, Yabao Chemical, was founded by Cai Tong, who leveraged his interdisciplinary knowledge in chemistry and economics to establish a unique position in the fine chemical industry [2][3] - Yabao Chemical has focused on the CDMO (Contract Development and Manufacturing Organization) segment in fine chemicals, particularly in innovative pharmaceuticals and agrochemicals, leading to its successful listing on the capital market [2][3] Business Development - Yabao Chemical has deepened its core business layout, particularly in the pharmaceutical sector, by signing a strategic cooperation agreement with leading domestic pharmaceutical company, Hengrui Medicine, to enhance the quality and efficiency of its pharmaceutical business [3] - The company’s Malta base serves as a bridge for international business, equipped with EU GMP certification and formulation repackaging capabilities, facilitating domestic pharmaceutical companies' expansion into overseas markets [3] - In the agrochemical intermediate sector, Yabao Chemical focuses on green, efficient, and low-toxicity innovative agrochemical CDMO business, maintaining strategic partnerships with international agricultural companies such as Corteva, Bayer, and FMC [3] Innovation and Investment - During the 14th Five-Year Plan period, Yabao Chemical has invested nearly 600 million yuan in research and development, positioning technology innovation as its core development engine [3] - The company has established an AI research and development laboratory to build an intelligent R&D system, solidifying its technological advantages in the industry [3] Recognition and Contributions - Cai Tong has received various accolades for his contributions to the industry and society, including the 2010 Taicang City First Lou Dong Talent Award and the 2013 Outstanding Person in China's Service Outsourcing Award [4] - He holds multiple positions, including a board member at Fudan University and vice president of the Fudan University Chemistry Alumni Association, contributing to talent cultivation and regional industrial collaboration [4]

Core Insights - The company, Yabao Chemical, has established itself as a leader in the fine chemical sector by focusing on technology-driven and core business strategies, particularly in the CDMO segment for innovative pharmaceuticals and agrochemicals [1][2]. Group 1: Company Background - Founded by Cai Tong, Yabao Chemical has leveraged a unique combination of expertise in chemistry and economics to navigate the fine chemical industry [1]. - The company has successfully listed on the capital market, becoming a benchmark in the domestic fine chemical field [1]. Group 2: Business Development - Yabao Chemical has intensified its core business layout, particularly in the pharmaceutical sector, by signing strategic cooperation agreements with leading domestic pharmaceutical companies like Heng Rui Medicine, focusing on key areas such as oncology and cardiovascular diseases [2]. - The Malta base serves as an international business hub with EU GMP certification, facilitating domestic pharmaceutical companies' expansion into overseas markets [2]. - In the agrochemical sector, the company emphasizes green, efficient, and low-toxicity innovative CDMO services, maintaining strategic partnerships with international firms like Corteva, Bayer, and FMC [2]. Group 3: Innovation and Investment - During the 14th Five-Year Plan period, Yabao Chemical has invested nearly 600 million yuan in research and development, prioritizing technological innovation as a core growth engine [2]. - The establishment of an AI research laboratory reflects the company's commitment to building an intelligent R&D system, solidifying its technological advantages in the industry [2]. Group 4: Recognition and Contributions - Cai Tong has received various accolades for his contributions to the industry and society, including the 2010 Taicang City First Lou Dong Talent Award and the 2013 Outstanding Person in China's Service Outsourcing Award [3]. - He holds multiple positions in educational and industry associations, contributing to talent cultivation and regional industrial collaboration [3].

Core Viewpoint - The company indicates that the change in gross margin for pharmaceutical intermediates in 2024 is primarily due to adjustments in product structure [1] Group 1 - The company will provide relevant data regarding the gross margin for pharmaceutical intermediates in 2025 in future periodic reports [1] - The company emphasizes its commitment to fulfilling information disclosure obligations in accordance with legal regulations [1]

Group 1 - The core point of the news is that Yabao Chemical has pledged 87.87 million shares, which accounts for 34.09% of its total holdings [1] - As of the announcement date, Yabao Chemical's market capitalization is 6.7 billion yuan [2] - The revenue composition for Yabao Chemical for the first half of 2025 shows that the chemical segment contributes 93.01%, other businesses 4.15%, and the environmental industry 2.85% [1]

证券代码：300261 证券简称：雅本化学 公告编号：2025-081 三、股东股份累计质押的情况 截至本公告日，上述股东及其一致行动人所持质押股份情况如下： | | | | | | | | 已质押股份 | | 未质押股份 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | 占其 | 占公 | 情况 | | 情况 | | | 股东名 | 持股数量 | 持股 | 本次质押前 | 本次质押后 | 所持 | 司总 | 已质押股 | 占已 | 未质押股 | 占未 | | 称 | （股） | 比例 | 质押股份数 | 质押股份数 | 股份 | 股本 | | 质押 | | 质押 | | | | (%) | 量 | 量 | 比例 | | 份限售和 | 股份 | 份限售和 | 股份 | | | | | | | | 比例 | 冻结数量 | | 冻结数量 | | | | | | | | (%) | | （股） | 比例 | （股） | 比例 | | | | | | | | | | (%) | | (%) | | 宁 ...

Core Viewpoint - The company announced that its controlling shareholder, Ningbo Yabao Holdings Co., Ltd., has pledged 21 million shares of the company, which represents 8.15% of its holdings and 2.18% of the company's total share capital. The pledge is for financing purposes and commenced on December 9, 2025 [1]. Summary by Relevant Categories Shareholder Actions - Ningbo Yabao Holdings Co., Ltd. pledged 21 million shares of the company [1] - The pledged shares account for 8.15% of the shareholder's total holdings [1] - The pledged shares represent 2.18% of the company's total share capital [1] Financing Purpose - The purpose of the share pledge is for financing [1] - The pledge started on December 9, 2025 [1]

与此同时，在由上海证券报·中国证券网主办的2025"上证鹰·金质量"评选活动中，雅本化学再获"科技创新奖"。该奖项聚焦企业在技术研发、产品创新及产 业升级方面的突出贡献，雅本化学凭借其在研发能力建设、工艺技术改进及绿色化学实践等领域的持续投入与突破，赢得了评委的一致认可。 近年来，雅本化学坚持"创新驱动+绿色可持续"双轮驱动赋能创新医药、创新农药双主业发展，持续加大研发投入，推动核心产品技术升级，同时积极构建 完善的ESG管理体系，提升企业综合竞争力。此次连获两项大奖，不仅是对公司过往成绩的肯定，更为其未来高质量发展注入强劲动力。 2025年12月，在资本市场持续强化高质量发展导向的背景下，雅本化学（300261）（300261.SZ）凭借其在科技创新与环境、社会及治理（ESG）领域的突 出表现，连续获得两项主流证券媒体权威奖项，进一步巩固其在行业中的领先地位。 在"第十九届上市公司价值评选"中，雅本化学荣获"上市公司ESG百强"奖项，公司董事长蔡彤先生亦被授予"中国上市公司年度ESG先锋人物"称号。该评选 由证券时报主办，旨在表彰在可持续发展、社会责任和公司治理方面表现卓越的上市公司。雅本化学此次获奖，充分 ...